BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Press Releases

  bioAffinity Technologies Launches New Study To Expand Use of CyPath® Lung Technology for Asthma and COPD Diagnosis and Treatment

  April 28, 2026

   · 

  6 min read
• Press Releases

  Veracyte Announces New Data at AUA 2026 Highlighting the Power of the Decipher Portfolio to Advance Personalized Care in Urologic Cancers

  April 28, 2026

   · 

  8 min read
• Press Releases

  Avenzo Therapeutics Advances the Combination of CDK4 Selective Inhibitor (AVZO-023) with CDK2 Selective Inhibitor (AVZO-021) in Ongoing Phase 1/2 ORION-1 Study in HR+/HER2- Breast Cancer

  April 28, 2026

   · 

  3 min read
• Press Releases

  CorVista Health Announces Collaboration with Mayo Clinic to Advance Next-Gen Pulmonary Hypertension Diagnosis

  April 28, 2026

   · 

  3 min read
• Press Releases

  Orca Bio Announces U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to Orca-Q® for the Treatment of High-Risk Hematologic Malignancies

  April 28, 2026

   · 

  3 min read
• Press Releases

  MustGrow Receives Georgia Registration for TerraSante(TM) Biofertility Product

  April 28, 2026

   · 

  5 min read
• 

  Press Releases

  Restart Life Sciences’ Wholly Owned Subsidiary Holy Crap Foods Launches on Walmart Canada’s Digital Marketplace

  April 28, 2026

   · 

  6 min read
• Press Releases

  Envoy Medical Highlights First Clinical Data Presentations from Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear Implant

  Positive Initial 6-Month Data from First 10 Patients and Improvements in Speech Understanding and Quality of Life Scores Presented; Additional Presentations Scheduled in Early May Details to be Discussed During Fireside Chat on April 29, 2026 at 4:30 pm ET

  April 28, 2026

   · 

  10 min read
• 

  Mergers & acquisitions

  AbbVie sinks talons into KRAS with right to buy Kestrel for up to $1.45B

  AbbVie is setting up a shot to buy Kestrel Therapeutics down the line, as the biotech doses patients in a Phase 1 trial for the oral pan-KRAS inhibitor KST-6051 in solid tumors.
  

  April 28, 2026

   · 

  1 min read

   · 

  Annalee Armstrong
• Press Releases

  C-Ray Therapeutics Receives FDA Acceptance of Type II Drug Master File for Copper-64 (Cu-64)

  April 28, 2026

   · 

  3 min read